ConductScience.org, home

Paper1691027

Raynaud's syndrome.

Cooke ED and 1 other. BMJ, 1990. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Raynaud's syndrome. Papers, record 1691027. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1691027

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Raynaud's syndrome.
PubMed
Journal
BMJ
PubMed
Year
1990
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.9
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cooke EDE D
2Nicolaides ANA N

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Raynaud DiseaseMajor topic
Angiotensin-Converting Enzyme Inhibitors
Cardiovascular Agents
Epoprostenol
Female
Humans
Iloprost
Moxisylyte
Nifedipine

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in2344496Raynaud's syndrome.https://conductscience.org/library/papers/2344496PubMed
Comment in2344545Raynaud's syndrome.https://conductscience.org/library/papers/2344545PubMed

Download CSV of comments and corrections

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12941573Selective antagonism of S2-serotonergic receptors relieves but does not prevent cold induced vasoconstriction in primary Raynaud's phenomenon.J Rheumatol1986https://conductscience.org/library/papers/2941573PubMed
26411898Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid.J Pharmacol Exp Ther1983https://conductscience.org/library/papers/6411898PubMed
33307894Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.Br J Dermatol1987https://conductscience.org/library/papers/3307894PubMed
42447572Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.Postgrad Med J1987https://conductscience.org/library/papers/2447572PubMed
53322358The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon.Br J Dermatol1987https://conductscience.org/library/papers/3322358PubMed
62449871Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.Ann Rheum Dis1988https://conductscience.org/library/papers/2449871PubMed
76416474Role of cold and emotional stress in Raynaud's disease and scleroderma.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6416474PubMed
86316965Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5 omega 3).Biochem Biophys Res Commun1983https://conductscience.org/library/papers/6316965PubMed
96318123Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid.Nature1984https://conductscience.org/library/papers/6318123PubMed
106432198Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6432198PubMed
112860386Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment of Raynaud's phenomenon.Lancet1985https://conductscience.org/library/papers/2860386PubMed
124025925Influence of the menstrual cycle on Raynaud's phenomenon and on cold tolerance in normal women.Angiology1985https://conductscience.org/library/papers/4025925PubMed
132412780Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.Drugs1985https://conductscience.org/library/papers/2412780PubMed
144083568CL115,347, an analogue of prostaglandin E2. Peripheral circulatory effects of single ascending doses administered transdermally in normal subjects and in patients with Raynaud's phenomenon.Angiology1985https://conductscience.org/library/papers/4083568PubMed
154087271Induced vasodilation as a home treatment for Raynaud's disease.J Rheumatol1985https://conductscience.org/library/papers/4087271PubMed
163081460Double-blind randomized trial of nitroderm TTS in the treatment of Raynaud's phenomenon.Isr J Med Sci1986https://conductscience.org/library/papers/3081460PubMed
173280190Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.Clin Immunol Immunopathol1988https://conductscience.org/library/papers/3280190PubMed
182454140Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue.Br J Rheumatol1988https://conductscience.org/library/papers/2454140PubMed
193054105Fish oils--their significance to human health.J R Soc Med1988https://conductscience.org/library/papers/3054105PubMed
203207617Hand warming as a treatment for Raynaud's phenomenon in systemic sclerosis.Br J Dermatol1988https://conductscience.org/library/papers/3207617PubMed

See all 37 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
8882128Increased capillary permeability in systemic sclerosis: help or hindrance?Ann Rheum Dis1996https://conductscience.org/library/papers/8882128PubMed
2344545Raynaud's syndrome.BMJ1990https://conductscience.org/library/papers/2344545PubMed
2344496Raynaud's syndrome.BMJ1990https://conductscience.org/library/papers/2344496PubMed
2060571Once daily felodipine in patients with primary Raynaud's phenomenon.Eur J Clin Pharmacol1991https://conductscience.org/library/papers/2060571PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1691027

GET https://conductscience.org/api/papers/v1/1691027/references?page=2